4th Aug 2014 15:27
Ducat Ventures plc
(the "Company")
Change of name to OptiBiotix Health plc
Ducat Ventures plc (AIM: DUC), which will become a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, confirms that it's proposed change of name to OptiBiotix Health plc has now been registered at Companies House and is therefore effective.
Trading in the Company's shares on AIM under the new name of OptiBiotix Health plc (AIM: OPTI) will take effect from 5 August 2014, from which date further information can be found on the Company's corporate website: www.optibiotix.com
Ducat Ventures plc | www.ducatventures.co.uk |
Adam Reynolds, Executive Chairman | Contact via Walbrook below |
Cairn Financial Advisers LLP | Tel: 020 7148 7900 |
Liam Murray / Avi Robinson | |
Peterhouse Corporate Finance Ltd | Tel: 020 7469 0936 |
Lucy Williams / Duncan Vasey | |
Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
Paul McManus | Mob: 07980 541 893 |
Anna Dunphy | Mob: 07876 741 001 |
Related Shares:
OptiBiotix Health